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Abstract 20 
 21 
The ATP synthase which provides aerobic eukaryotes with ATP, organizes into a 22 
membrane-extrinsic catalytic domain, where ATP is generated, and a membrane-23 
embedded FO domain that shuttles protons across the membrane. We previously 24 
identified a mutation in the mitochondrial MT-ATP6 gene (m.8969G>A) in a 14-year-25 
old Chinese female who developed an isolated nephropathy followed by brain and 26 
muscle problems. This mutation replaces a highly conserved serine residue into 27 
asparagine at amino acid position 148 of the membrane-embedded subunit a of ATP 28 
synthase. We showed that an equivalent of this mutation in yeast (aS175N) prevents 29 
FO-mediated proton translocation. Herein we identified four first-site intragenic 30 
suppressors (aN175D, aN175K, aN175I, and aN175T), which, in light of a recently 31 
published atomic structure of yeast FO, indicating that the detrimental consequences 32 
of the original mutation result from the establishment of hydrogen bonds between 33 
aN175 and a nearby glutamate residue (aE172) that was proposed to be critical for the 34 
exit of protons from the ATP synthase towards the mitochondrial matrix. Interestingly 35 
also, we found that the aS175N mutation can be suppressed by second-site 36 
suppressors (aP12S, aI171F, aI171N, aI239F, and aI200M), of which some are very 37 
distantly located (by 20-30 Å) from the original mutation. The possibility to 38 
compensate through long-range effects the aS175N mutation is an interesting 39 
observation that holds promise for the development of therapeutic molecules.  40 
 41 
 42 
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 46 
1. Introduction 47 
The ATP synthase is found in the inner mitochondrial membrane and catalyzes the 48 
last step in oxidative phosphorylation (OXPHOS) by producing ATP from ADP and 49 
inorganic phosphate using the transmembrane proton gradient, also called the 50 
proton-motive force (pmf), generated during the transfer of electrons to oxygen by the 51 
respiratory chain (RC) complexes (I–IV) [1]. Cryo-EM structures of the bovine Bos 52 
taurus and yeasts Yarrowia lipolytica and Saccharomyces cerevisiae F1FO ATP 53 
synthases, that are basically of the same subunit composition and structural 54 
construction as the human enzyme, have been described recently [2-5]. The ATP 55 
synthase organizes into a membrane-extrinsic F1 catalytic and a membrane-56 
embedded FO domain that are connected by a peripheral and central stalk [4, 6]. ATP 57 
synthase exists as dimers [2, 6] that assemble into long ribbons important for cristae 58 
formation [7, 8], which is crucial with respect to accommodation within the 59 
mitochondrial inner membrane of the OXPHOS respiratory chain complexes and the 60 
ATP synthase in most efficient and native way. 61 
Within the FO, protons are shuttled across the membrane by subunit a and a 62 
ring of identical subunits c (8 in mammals, 10 in yeast). Hydrophilic amino acids of 63 
subunit a allow protons to enter the FO from the IMS. Approximately in the middle of 64 
the membrane the proton can bind to a highly conserved acidic residue of subunit c 65 
helix 2 (cH2) (cE59 in H. sapiens) located at the outer surface of the c-ring. The 66 
binding of a proton on this carboxylate residue disrupts a previously established 67 
electrostatic interaction of cE59 with a highly conserved positively charged arginine 68 
residue in subunit a membrane helix 5 (aH5) (aR159 in H. sapiens) [5, 9, 10]. This 69 
arginine acts as an electrostatic separator between the proton pathway from the IMS 70 
to the middle of the membrane and a second, spatially separated pathway that allow 71 
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incoming protons still bound on the c-ring glutamate to be released into the matrix 72 
[11]. The operation direction of this process is primarily driven by the ion gradient that 73 
causes a ratchet type mechanism of the neutralized c-ring glutamate in the 74 
hydrophobic membrane, which does energetically not allow the back stepping without 75 
externally applied force [9, 10]. After an almost complete revolution of the c-ring, the 76 
glutamate is deprotonated in the aqueous exit channel [12] and the proton is moved 77 
towards the mitochondrial matrix [2, 4-6, 13]. The c-ring is tightly bound to the central 78 
stalk, a three subunit subcomplex of F1 ), which induces upon rotation cyclic 79 
conformational changes in the (αβ)3 catalytic head of F1 that favor synthesis and 80 
release of ATP [14], according to the binding change mechanism [1].  81 
Devastating human neuromuscular disorders (e.g. Neuropathy, Ataxia, and 82 
Retinitis Pigmentosa (NARP) and Maternally Inherited Leigh Syndrome (MILS)) have 83 
been associated to numerous mutations in subunit a [15]. This protein is encoded by 84 
the mitochondrial MT-ATP6 gene. Human cells contain up to thousands copies of 85 
mtDNA [16]. Mutations in this DNA are highly recessive and usually co-exist in 86 
patient’s cells and tissues with wild type mtDNA molecules, a situation referred to as 87 
heteroplasmy. These features make it difficult to precisely know how specific 88 
pathogenic mtDNA mutations influence oxidative phosphorylation. To better 89 
characterize the effects of disease-causing subunit a mutations, we exploited unique 90 
features of Saccharomyces cerevisiae. Mitochondria from this single-celled fungus 91 
and humans show many similarities [17-21], and mitochondrial genetic transformation 92 
can be achieved in this yeast in a highly controlled fashion, by the biolistic delivery 93 
into mitochondria of in-vitro-made mutated mtDNA fragments, followed by their 94 
integration into wild type mtDNA by homologous DNA recombination [22]. Being 95 
unable to stably maintain heteroplasmy [23], it is easy to obtain yeast homoplasmic 96 
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populations where all mtDNA molecules carry a mutation of interest. Owing to its 97 
good fermenting capacity, yeast models of human mitochondrial diseases can be 98 
kept alive when provided with sugars like glucose even when oxidative 99 
phosphorylation is completely inactivated [24, 25].  100 
We used this yeast-based approach to investigate the impact on ATP 101 
synthase of nine subunit a missense mutations identified in patients [15, 25-33]. 102 
Some of these mutations were found to compromise incorporation of subunit a into 103 
ATP synthase, whereas others prevent the functioning of FO without minor or any 104 
assembly defect. While these observations are interesting, it is often difficult to 105 
understand why the mutations are detrimental. Further information may be obtained 106 
by the isolation of intragenic suppressor mutations. In doing so, it is possible to 107 
identify novel amino acids at the original mutation site that are compatible with 108 
subunit a function as well as second-site suppressors that make the primary mutation 109 
no longer or less detrimental.  110 
 We here applied this suppressor genetics approach to a mutation in subunit a 111 
(m.8969G>A, aS148N) that we previously identified in a 14-year-old Chinese female 112 
who initially developed an isolated nephropathy followed by a complex clinical 113 
presentation with brain and muscle problems [33]. With an equivalent of this mutation 114 
(aS175N), yeast fails to grow on non-fermentable carbon sources due to a lack of FO-115 
mediated proton transfer [33]. The isolation of respiratory sufficient revertants from 116 
the mutant aS175N led us to identify four first-site (aN175D, aN175K, aN175I, and aN175T) 117 
and five second-site (aP12S, aI171F, aI171N, aI239F, and aI200M) suppressor mutations 118 
restoring to varying degree ATP synthase function. The results, in the light of a 119 
recently published atomic structure of yeast FO [5, 34], indicate that the detrimental 120 
consequences of the aS175N mutation may result from the establishment of hydrogen 121 
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bonds between aN175 and aE172, a residue that was proposed to be critical for the exit 122 
of protons from ATP synthase towards the mitochondrial matrix [5]. 123 
 124 
 125 
 126 
  127 
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2. Materials and Methods 128 
2.1. Growth media and genotypes  129 
The media used for growing yeast were: YPGA (1% Bacto yeast extract, 1% Bacto 130 
Peptone, 2% or 10% glucose, 40 mg/L adenine), YPGalA (1% Bacto yeast extract, 131 
1% Bacto Peptone, 2% galactose, 40 mg/L adenine), YPEGA (1% Bacto yeast 132 
extract, 1% Bacto Peptone, 3% ethanol, 2% glycerol, 40 mg/L adenine), W0 (2% 133 
glucose, 0.67% Nitrogen base with ammonium sulfate from Difco). SP1: 0.1% 134 
glucose, 0.25% yeast extract, 50 mM potassium acetate. Solid media were obtained 135 
by adding 2% Bacto Agar (Difco, Becton Dickinson). The genotypes of the strains 136 
used in this study are listed in Table 1. Growth curves were established with the 137 
Bioscreen CTM system. 138 
2.2. Selection of respiratory-sufficient revertants from the yeast aS175N mutant 139 
The aS175N mutant (strain RKY105) was subcloned on rich 2% glucose plates. Forty 140 
single colonies were picked up and individually grown in 10% glucose. Glucose was 141 
removed from the cultures by two washings with water and 108 cells from each 142 
culture were spread on rich glycerol/ethanol (YPEGA) plates. The plates were 143 
incubated at 28°C for 25 days. Maximum 3 revertants per plate were retained for 144 
further analysis. The revertants were purified by subcloning on glucose plates. They 145 
were crossed on W0 minimal medium to strain D273-10B/60 devoid of mtDNA (o), 146 
and the diploid cells were tested for their ability to grow on glycerol. The ATP6 gene 147 
was amplified by PCR with primers oATP6-1 148 
5’TAATATACGGGGGTGGGTCCCTCAC and oATP6-10 149 
5’GGGCCGAACTCCGAAGGAGTAAG, and sequenced entirely. 150 
 151 
2.3. Bioenergetics analyses 152 
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Mitochondrial enzyme assays and membrane potential analyses were performed on 153 
mitochondria isolated from yeast cells grown in rich galactose (YPGalA) at 28°C. 154 
Mitochondria were prepared by the enzymatic method, as described [35]. Oxygen 155 
consumption rates were measured with a Clark electrode in 0.65 M mannitol, 0.36 156 
mM EGTA, 5 mM Tris/phosphate, 10 mM Tris/maleate pH 6.8 (respiration buffer), as 157 
described [36]. For ATP synthesis rate measurements, the mitochondria (0.15 mg/ml) 158 
were placed in a 1 ml thermostatically controlled chamber at 28°C in respiration 159 
buffer. The reaction was started by adding 4 mM NADH and 750 µM ADP; 100 µl 160 
aliquots were taken every 15 seconds (30 seconds for strains with a slow oxygen 161 
consumption rate) and the reaction was stopped by adding 3.5% perchloric acid and 162 
12.5 mM EDTA. Samples were neutralized to pH 6.5 by KOH and 0.3 M MOPS. ATP 163 
was quantified using the Kinase-Glo Max Luminescence Kinase Assay (Promega) 164 
and a Beckman Coulter's Paradigm Plate Reader. Part of the ATP produced by the 165 
F1FO-ATP synthase was assessed using oligomycin (20 μg/mg of proteins). 166 
Variations in transmembrane potential (ΔΨ) were evaluated in the respiration buffer 167 
using Rhodamine 123 (0.5 μg/ml), with λexc of 485 nm and λem of 533 nm under 168 
constant stirring with a Cary Eclipse Fluorescence Spectrophotometer (Agilent 169 
Technologies, Santa Clara, CA, USA) [37]. 170 
2.4. BN-PAGE analyses 171 
Blue native-PAGE experiments were carried out as described [38]. 200 µg of 172 
mitochondrial proteins suspended in 100 µl extraction buffer (30 mM HEPES pH=6,8, 173 
150 mM potassium acetate, 12% glycerol, 2 mM 6-aminocaproic acid, 1 mM EGTA, 174 
1.5% digitonin (Sigma)), supplemented with one protease inhibitor cocktail tablet from 175 
Roche. After 30 min incubation on ice, the extracts were cleared by centrifugation 176 
(14,000 rpm, 4°C, 30 min), supplemented with 4.5 µl of loading dye (5% Serva Blue 177 
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G-250, 750 mM 6-aminocaproic acid) and run on NativePAGETM 3-12% Bis-Tris Gels 178 
(Invitrogen). After transfer onto a PVDF membrane, ATP synthase complexes were 179 
detected using polyclonal antibodies raised against α-F1 subunit (Atp1p) or subunit a 180 
(Atp6) of yeast ATP synthase, at 1:10000 dilution. 181 
2.5. Amino-acid alignments and topology of subunit a mutations. 182 
Multiple sequence alignment of ATP synthase a-subunits of various origins was 183 
performed using COBALT [39]. The topology of the mutations within FO structure is 184 
based on the atomic structure of FO recently published [5]. The shown figures were 185 
built using PyMOL molecular graphic system. 186 
2.6. Statistical analysis 187 
At least three biological and three technical replicates for performed for all  188 
experiments. The t-test was used for all data sets. Significance and confidence level 189 
was set at 0.05. 190 
 191 
  192 
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3. Results 193 
Yeast subunit a (also referred to as subunit 6 or Atp6p) is synthesized as a pre-194 
protein of which the first ten residues are removed during assembly [33]. The serine 195 
residue at position 148 of human subunit a that is changed into asparagine by the 196 
m.8969G>A mutation corresponds to aS175 in the non-processed yeast protein (Fig. 197 
1). As we have shown, a yeast model of the m.8969G>A mutation (aS175N) fails to 198 
grow on non-fermentable substrates like glycerol owing to a lack in FO-mediated 199 
proton transport [33]. Compared to wild type (WT) yeast, fully assembled F1FO 200 
complexes accumulate slightly less in the aS175N mutant and free F1 particles are 201 
detectable in BN-gels ([33], see also below). This effect may be in part or mostly due 202 
to a higher propensity of the aS175N mutant to produce 
-/0 cells issued from large 203 
deletions in mtDNA (30% vs <5% in the WT). A decreased mtDNA stability was 204 
observed in many other yeast mutants in which ATP synthase function is severely 205 
compromised [40]. Thus, rather than a wide impact on ATP synthase structure, the 206 
aS175N mutation most likely locally disturbs this structure.  207 
 3.1. Isolation of revertants from the mutant aS175N 208 
We isolated revertants from the aS175N mutant, using a previously described 209 
procedure [41]. To ensure genetic independence, they were isolated from different 210 
aS175N subclones grown in liquid glucose. The cells were spread on glycerol medium 211 
(108 cells/plate). Revertants appeared at a 10-7 frequency. 73 isolates were retained 212 
for analysis. After crossing with a strain (D273-10B/60) having a wild type nucleus 213 
and totally devoid of mitochondrial DNA (o), the revertants were still able to grow on 214 
glycerol indicating that the suppressor mutations were nuclear dominant or located in 215 
mitochondrial DNA. Most (>95%) of the spores from at least 6 complete tetrads 216 
issued from the diploid revertants were able to grow on glycerol (not shown) 217 
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indicating that the suppressor mutations had a mitochondrial origin, otherwise they 218 
would have displayed a mendelian (2:2) segregation. The gene ATP6 was entirely 219 
sequenced in each revertant. In 60 revertants, a novel mutation in ATP6 (intragenic 220 
suppressor) was identified (Table 2). Two nucleotide changes were introduced at 221 
codon 175 to replace serine by asparagine (TCT175AAT). Not surprisingly, none of 222 
the sequenced revertants had recovered a wild type ATP6 gene because the 223 
frequency of a specific double nucleotide change is far below 10-10. However six 224 
clones had again a serine codon at position 175 that was derived from a single 225 
nucleotide change (AAT175AGT); they all grew on glycerol like wild type yeast (not 226 
shown) and were not analyzed further. Four other first-site mutations introduced 227 
novel amino acid residues at position 175: AAT175GAT (aN175D) in two clones, 228 
AAT175AAA (aN175K) in one clone, AAT175ATT (aN175I) in two clones, and AAT175ACT 229 
(aN175T) in one clone. Henceforth, the four different pseudo first-site reversions will 230 
be designated as aS175D (instead of aN175D), aS175K, aS175I, and aS175T to indicate 231 
the amino-acid changes relative to the wild type protein sequence. 232 
In 48 revertants, respiration-dependent growth recovery resulted from a single 233 
nucleotide change in ATP6 not located at codon 175 (second-site intragenic 234 
suppressor): CCA12TCA (aP12S) in 3 clones, ATT171TTT (aI171F) in 8 clones, 235 
ATT171AAT (aI171N) in 1 clone, ATT239TTT (aI239F) in 35 clones, and ATT200ATA 236 
(aI200M) in 1 clone (Fig. 1, Table 2). 237 
Finally, the remaining 13 revertants had no other mutation in ATP6 than the 238 
original one, aS175N. We considered the possibility that these revertants were issued 239 
from an extragenic suppressor in one of the two other mitochondrial ATP synthase 240 
genes, ATP8 and ATP9, but no mutation was detected in these genes. These 241 
revertants were not analyzed further. 242 
12 
 
Figure 1. Sequence alignments of subunits a from various sources and 243 
conservation of the residues modified by the suppressors of S175N. The aligned 244 
subunits a are from Homo sapiens (H.s.), Bos taurus (B.t.), Saccharomyces 245 
cerevisiae (S.c.), Schizosaccharomyces pombe (S.p.), Yarrowia lipolytica (Y.l.) and 246 
Escherichia coli (E.c.). The magenta and green arrows mark the locations of the 247 
pseudo first-site and the second-site intragenic mutations found in this study, 248 
respectively. The maroon arrow marks the original S175N mutation. At the top and 249 
bottom, the residues are numbered according to the unprocessed S.c. protein (the 250 
first 10 residues are cleaved during assembly of the protein [42] and to E.c. protein, 251 
respectively. Leader peptide sequences in the subunits a of S.c., S.p. and Y.l. [43] 252 
are marked in yellow. Strictly conserved residues are in white characters on a red 253 
background while similar residues are in red on a white background with blue frames. 254 
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α-helices in the S.c. and E.c. proteins, marked above and below amino the 255 
alignment, are according to Y.l. and E.c. structures, respectively [2, 5, 44]. The 256 
essential arginine is on a blue background. 257 
 258 
3.2. Properties of the revertants. 259 
3.2.1. Respiratory growth and mtDNA stability 260 
Of the nine different intragenic suppressors we isolated from the aS175N mutant, four 261 
(aS175I, aS175T, aI171F, and I200M) conferred a good growth on glycerol whereas the 262 
others (aS175D, aS175K, aP12S, aI239F, and aI171N) resulted in a slow respiratory 263 
growth phenotype, at all temperatures tested (20°C, 28°C, 36°C) (shown for 28°C in 264 
Fig. 2A,B)). All the revertants had a much better genetic stability than the aS175N 265 
mutant as evidenced by a reduced accumulation of -/o cells in cultures (10% or less 266 
vs 35%) (Table 3). 267 
 268 
Figure 2. Growth of mutant strains. (A) Fresh liquid glucose cultures of wild type 269 
yeast, mutant aS175N and its revertants were serially diluted and spotted on rich 270 
glucose and rich glycerol/ethanol plates. The glucose and glycerol plates were 271 
photographed after 3 and 7 days of incubation at 28°C, respectively. (B) Growth 272 
curves in liquid rich glycerol/ethanol at 28°C. 273 
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 274 
  3.2.2. Respiration and ATP synthesis 275 
Improvement of ATP synthase function by the suppressors was evaluated first by 276 
measuring oxygen consumption and ATP synthesis rates in isolated mitochondria. As 277 
shown previously, yeast atp6 mutations including aS175N that compromise ATP 278 
synthase activity usually result in a diminished respiration rate mainly because of a 279 
lower content in complex IV ([15, 29, 33, 45] Table 3). Thus, decreased ATP 280 
synthesis rate in atp6 mutants is not primarily due to a reduced rate of electron 281 
transfer to oxygen but to some defect in the ATP synthase that secondarily impacts 282 
respiration. Oxygen consumption was assessed with NADH as an electron donor, 283 
alone (basal, state 4 respiration), after further addition (75 µM) of ADP (state 3, 284 
phosphorylating conditions) or in the presence of the membrane proton ionophore 285 
CCCP (carbonyl cyanide m-chlorophenylhydrazone) (uncoupled respiration). Under 286 
state 4, respiration is controlled by the passive permeability to protons of the inner 287 
membrane. Under state 3, most of the protons return to the matrix through the ATP 288 
synthase so that the contribution to respiration of passive proton leaks becomes very 289 
small. In the presence of CCCP, the maintenance of an electrical potential (ΔΨ) 290 
across the inner membrane is impossible and respiration becomes maximal. We also 291 
measured complex IV activity using ascorbate/TMPD (N,N,N′,N′-tetramethyl-292 
phenylenediamine) in the presence of CCCP. Mitochondrial ATP synthesis rate was 293 
measured using NADH as a respiratory substrate in the presence of a large excess 294 
(750 µM) of external ADP, conditions under which ATP is synthesized exclusively by 295 
ATP synthase using the proton-motive force generated by complexes III and IV (there 296 
is no complex I in S. cerevisiae). 297 
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 Consistent with their good growth on glycerol, mitochondria from strains 298 
aS175I, aS175T, aS175N+aI171F and aS175N+aI200M efficiently respired and produced 299 
ATP almost like those from wild type yeast (Table 3). Accordingly, in all the slowly 300 
growing revertants ATP synthesis rate was diminished by 80-90% compared to the 301 
WT. ATP synthase assembled and accumulated quite efficiently in all the revertants 302 
(Fig. 3). Regarding the Westerns with Atp6 antibodies, it apparently seems that there 303 
is much less ATP synthase in the aP12S revertant whereas the Atp1 antibodies did 304 
not reveal a lack of this enzyme in this strain. The most likely explanation is that the 305 
aP12S mutation is within the sequence of subunit a (a.a. 11-23) that we used to raise 306 
the Atp6 antibodies, and that because of this these antibodies reacted less efficiently 307 
with the aP12S subunit. 308 
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Figure 3. Levels of ATP synthase in the revertants. Proteins were extracted from 309 
the mitochondrial samples used in the bioenergetics experiments described in Table 310 
3 with 1.5 gr digitonin per gr of proteins and separated by BN-PAGE (200 μg per 311 
lane). The proteins were transferred onto PVDF membrane and probed with 312 
antibodies against subunit a (Atp6) or F1-subunit Atp1 of ATP synthase, revealing 313 
dimeric (V2) and monomeric (V1) F1FO complexes. The shown Westerns are 314 
representative of three independent experiments. 315 
 316 
3.2.3. Membrane potential  317 
The influence of the suppressor mutations was investigated further using Rhodamine 318 
123, a fluorescent cationic dye that can be used to monitor changes in mitochondrial 319 
membrane potential (ΔΨ) [37]. Increasing ΔΨ is followed by the uptake of the dye 320 
inside the matrix and concomitant fluorescence quenching. In a first set of 321 
experiments (Fig. 4A), we tested the capacity of externally added ADP to induce ΔΨ  322 
consumption. To this end, mitochondria were first fed with electrons from ethanol. 323 
Due to their strongly reduced capacity to respire, those from the mutant aS175N were 324 
poorly energized in comparison to WT mitochondria whereas ethanol induced a much 325 
larger ΔΨ variation in all the revertants. Normally, further adding a small amount of 326 
ADP induces a transient fluorescence increase due to ΔΨ consumption by the ATP 327 
synthase during phosphorylation of the added ADP. This was indeed observed in 328 
mitochondria from the WT and the revertants, whereas those from the aS175N mutant 329 
were virtually insensitive to ADP consistent with their very poor capacity to produce 330 
ATP (Table 3). However, in those revertants growing slowly on glycerol (aS175D, 331 
aS175K, aS175N+aP12S, aS175N+aI239F, and aS175N+aI171N) a much longer time was 332 
needed to recover the ethanol-induced ΔΨ compared to the WT and the revertants 333 
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with a good growth on glycerol (aS175I, aS175T, aS175N+aI171F, and aS175N+aI200M), 334 
reflecting the large differences in ATP synthesis rate between these strains. KCN 335 
was then added to inhibit complex IV, which, in mitochondria from the WT and the 336 
revertants resulted in a partial ΔΨ collapse. The remaining potential was due to FO-337 
mediated proton pumping coupled to hydrolysis of the ATP that accumulated in the 338 
mitochondrial matrix during phosphorylation of the added ADP, as evidenced by the 339 
loss of this potential by inhibiting ATP synthase with oligomycin. By contrast, no 340 
oligomycin-sensitive ΔΨ was observed in the aS175N mitochondria owing to their 341 
incapacity to produce ATP. 342 
In a second set of experiments (Fig. 4B), we directly tested the proton-343 
pumping activity of ATP synthase using externally added ATP independently of the 344 
respiratory chain. To this end, mitochondria were first energized with ethanol to 345 
remove the natural inhibitory peptide (IF1) of F1-ATPase. ΔΨ was then collapsed with 346 
KCN, and less than one minute later, thus well before IF1 rebinding [46], ATP was 347 
added. External ATP is counter-exchanged against ADP present in the matrix by the 348 
ADP/ATP translocase, which does not require any ΔΨ, and the ATP can then be 349 
hydrolyzed by F1 coupled to FO-mediated proton transport. Adding ATP promoted in 350 
mitochondria from the WT and the revertants a large and stable fluorescence 351 
quenching of the dye that was reversed upon inhibition with oligomycin, whereas 352 
aS175N mitochondria were mostly insensitive to ATP due to their inability to move 353 
protons through the FO. 354 
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Figure 4. Mitochondrial membrane potential. Variations in mitochondrial ΔΨ were 355 
monitored by fluorescence quenching of Rhodamine 123 in the mitochondria used for 356 
the bioenergetics experiments described in Table 3. The tracings in panel A show 357 
how the mitochondria respond to the addition of ADP, those in panel B reflect the 358 
proton-pumping activity of ATP synthase. The additions were 75 μM ADP, 0.5 μg/ml 359 
Rhodamine 123, 75 μg/mL mitochondrial proteins (Mito), 10 μL ethanol (EtOH), 2 mM 360 
potassium cyanide (KCN), 4 μg/mL oligomycin (oligo), and 4 μM carbonyl cyanide-m-361 
chlorophenyl hydrazone (CCCP). The shown tracings are representative of three 362 
experiments. 363 
 364 
3.3. Topological location of the mutations 365 
 The locations in the recently published atomic structure of yeast FO [5] of the 366 
mutations here described (aS175N, aS175D, aS175K, aS175I, aS175N, aP12S, aI171F, 367 
aI171N, aI239F, and aI200M) are shown in Fig. 5. The amino acid alignments in Fig. 1 368 
establish the correspondences with human subunit a residues. The six membrane-369 
associated helices of subunit a and the two transmembrane helices of subunit c are 370 
referred to as aH1-6 and cTM1-2 respectively (Fig. 5A). At the interface between the 371 
a-subunit and the c-ring, near the middle of the membrane, are two electrically 372 
charged residues (aR186 and cE59) directly involved in proton translocation. Being 373 
kinked, aH5 (residues 162-209) can follow the curvature of the c-ring and seal the 374 
two hydrophilic pockets that connect the a/c-ring interface to the intermembrane and 375 
matrix spaces. The N-term part of aH5 (residues 162-180, 31 Å long) is shorter than 376 
its C-term part (residues 184-209, 43 Å long), and aH6 (residues 219-257, 55 Å) is 377 
shorter and more straight than aH5, which creates a funnel-shaped cleft between 378 
subunit a and the c-ring accessible from the matrix (Fig. 5B). The mouth of this cleft 379 
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is surrounded by a short helix aHβ (residues 137-147) that connects aH4 and aH5, 380 
the C-terminal extremity of subunit a, and a five amino acid long loop (residues 85-381 
89) between aH2 and aH3. The cleft, into which points the essential aR186 residue, is 382 
15 Å long (from aR186 to aD254 or E172), 8 Å wide (from aD254 to aE172) and 16 Å deep 383 
(from aS175 to the C-terminus of the protein). It is bordered by polar or electrically 384 
charged residues on aH5 (aS250, aY251, aK253, aD254, aH259) and aH6 (aE172, aS175, 385 
aR179, aS182), two of which, aE172 and aD254, would be essential for moving protons 386 
out of the cleft [5, 34] (Fig. 5B,D). Since the others, as well as those surrounding cE59 387 
(cF48, cP49, cI52, cL53, cF55, cA56, cL57), cannot engage in hydrogen bonding, it is 388 
possible that water molecules inside the cleft help proton conduction towards the 389 
matrix.  390 
Although aS175 is highly conserved (Fig. 1), has a hydroxyl group that can 391 
exchange protons and is located in the n-side cleft, this residue is clearly not required 392 
for FO-mediated proton translocation. Indeed, as shown in this study, ATP synthase 393 
function was fully preserved with the presence at position 175 of an aliphatic side 394 
chain residue (aI175). These findings are in line with a previous study showing that 395 
replacing the equivalent serine in subunit a of E. coli by alanine had no detrimental 396 
consequences [47]. aI175 can orient towards the c-ring without any steric hindrance 397 
on E172 and preserve with aL164, aL167 and aI171 a non-polar environment around the 398 
c-ring (Fig. 5D). The absence of major functional defects with a threonine residue at 399 
position 175 (aT175) further supports a non-essential role for aS175. 400 
 Disruption of FO-mediated proton transport induced by aN175 possibly results 401 
from the establishment of two hydrogen bonds between aN175 amide and aE172 402 
carboxylate groups that are distant by 3.1 and 3.3 Å (Fig. 5B,C). As a result the 403 
glutamate would become unable to conduct protons out of the n-side cleft. 404 
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Alternatively, aN175 can orient towards the c-ring without making a direct hydrogen 405 
bond with the catalytic cE59 residue (because of a too long distance, 4 Å) (Fig. 5D). 406 
However, it will then impair rotation of the c-ring by clashing cA56 and cL57. Like 407 
aN175, aD175 can adopt the same two orientations towards either aE172 or the c-ring. 408 
However the electrostatic repulsion between aD175 and aE172 most likely favors the 409 
second one, which may explain the recovery of ATP synthase function when aN175 is 410 
replaced by aspartate. The poor suppressor activity of aD175 is possibly due to 411 
clashes with the c-ring and/or unproductive proton transfers. The suppressor activity 412 
of aK175 probably also result from the recovery of aE172 to conduct protons. Owing to 413 
its flexibility and hydrophobic alkyl moiety, the lysine side chain may easily adopt a 414 
conformation that preserves c-ring rotation. However due to its positive charge, a 415 
reduced strength of attraction for protons towards the matrix may be responsible for 416 
the slow and inefficient functioning of ATP synthase with aK175. 417 
The five-second site suppressors that make the aS175N mutation no longer or 418 
less detrimental all localize close to the a/c interface (Fig. 5E,F). Two are in proximity 419 
to the original mutation, at position 171 (aI171F and aI171N). ATP synthase function 420 
was fully restored with aF171. Replacement of aI171 by a rigid and bulkier 421 
phenylalanine group may structurally shift the position of aN175 towards the c-ring so 422 
as it can no longer interact with aE172 without affecting the sealing of the two 423 
hydrophilic pockets by aH5. Furthermore, as a highly hydrophobic residue, 424 
phenylalanine preserves the non-polar surface that aH5 (aL164, aL167, aL168, aI171, 425 
aL174, aA178, aA193, aL197, aI200, aL201, and aL204) and aH6 (aM225, aI229, aL232, aI236, 426 
aI239) provide in front of the c-ring so as to ease its rotation. The suppressor activity of 427 
aN171 is much less efficient compared to aF171, indicating that aN175 remains mostly 428 
21 
 
bound to aE172 and that the proton exchanging capacity of aN171 helps somehow the 429 
protons to quit the c-ring. 430 
 The three other second-site suppressors are remotely located from the original 431 
aS175N mutation, by 35 Å (aP12S, aI200M) or 23 Å (aI239F) on the p-side of the 432 
membrane (Fig. 5E). They are quite close to conserved residues presumably 433 
involved in the transport of protons from the intermembrane space (aE233 (H in E. 434 
coli), aN190, aQ240 and aH195 (E in E. coli)) to aR186. Interestingly, the aP12S 435 
suppressor belongs to a region of subunit a that does not exist in bovine and humans 436 
(Fig. 1). That it can upon mutation compensate for the aS175N change indicates that 437 
this region has an important function in yeast ATP synthase. Consistently, this region 438 
shows a rather good amino acid sequence conservation in those mitochondria where 439 
it is present. While it is difficult to provide a mechanistic explanation for these long-440 
distance interactions that improve FO-mediated proton transfer in the aS175N mutant 441 
this is, as discussed below, an interesting observation.  442 
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 443 
Figure 5. Topological locations of the mutations. (A) View of the entire c-ring and 444 
subunit a from the matrix and of the pathway along which protons are transported 445 
from the intermembrane space to the mitochondrial matrix. The side chains of the two 446 
residues essential to this transfer (aR186 and cE59) are drawn as stick with their 447 
carbon atoms in white. The p-side and n-side clefts are shown as grey surface. (B) 448 
The original aS175N mutation prevents by hydrogen bonding the nearby glutamate 449 
aE172 to move protons out the n-side cleft. (C) Zoom on the hydrogen bonds that 450 
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aN175 can potentially form with aE172 (D) View from the matrix showing the two 451 
possible orientations of aN175 towards either the c-ring (yellow) or aE172 (magenta). 452 
aF171 (yellow) is supposed to orient aN175 towards the c-ring, thus restoring the proton 453 
conducting activity of aE172, whereas aN175 remains oriented towards aE172 with aN171 454 
(magenta). (E) Enlargement of the region showing the five mutated residues (aS175, 455 
aP12, aI171, aI200, and aI239); their side chains are drawn as stick with their carbon 456 
atoms in yellow. Residues presumed to be important for proton transfer (aE172, aD234, 457 
aH195 and aD254) are represented as stick with their carbon atoms in white color. (F) 458 
Enlargement around the aP12S, aI200M and aI239F second-site suppressors. 459 
 460 
4. Conclusion 461 
With the recently described cryo-EM structures of F1FO ATP synthase from various 462 
mitochondrial origins it has become feasible to map at a molecular level discrete 463 
structural changes of this enzyme found to be responsible for human diseases. 464 
Although this is a major step towards a better comprehension of these diseases, it is 465 
generally difficult to understand how loss-of-function mutations act. The suppressor 466 
genetics approach used in this study help to understand how a pathogenic mutation 467 
in subunit a (aS148N in humans, aS175N in yeast) disrupts FO-mediated proton 468 
conduction. Our results reveal that despite its very strong evolutionary conservation 469 
and its capacity to exchange protons thanks to the presence of a hydroxyl group on 470 
its side chain, the mutated serine is by itself not directly involved in this activity. 471 
Indeed, consistent with a previous study in E. coli [47], ATP synthase function was 472 
fully regained by replacing the mutant asparagine with aliphatic residues that do not 473 
have the capacity to conduct protons. Thus, losing the serine is by itself not 474 
problematic, it is its replacement by asparagine that leads to the loss of FO function. 475 
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The most likely explanation that emerges from our suppressor genetic analysis and 476 
the atomic structure of yeast FO, is that the mutant asparagine neutralizes by 477 
hydrogen bonding the nearby glutamate (aE172) presumed to be critical for the exit of 478 
protons from the n-side hydrophilic cleft. 479 
 Very interestingly also, we show that the serine-to-asparagine change can be 480 
somewhat efficiently suppressed by mutations in other positions of subunit a 481 
(second-site suppressors). Thus, while being still present, the mutant asparagine 482 
ceases to be or is much less detrimental. Surprisingly, some of the second-site 483 
suppressors are within the p-side cleft that provides a pathway for protons from the 484 
intermembrane space. These suppressors must thus be responsible for long (20-30 485 
Å)-range effects that somehow disrupt the detrimental hydrogen bound between 486 
aE172 and aN175 or help the protons to find another route to reach the mitochondrial 487 
matrix. It is not unreasonable to imagine that drugs could as well undo an 488 
undesirable hydrogen bond by hitting the regions of subunit a modified by the 489 
suppressors. The approach used in this study is not only helpful to better understand 490 
how mutations of ATP synthase induce diseases, but may also open the door to 491 
drug-design therapeutic developments.  492 
 493 
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 Table 1. Genotypes and origins of yeast strains. 657 
Strain Nuclear genotype mtDNA Source 
MR6 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
  
[48] 
D273-10B/60 Matα met6 
o
 [49] 
DFS160 MATα leu2∆ ura3-52 ade2-101 arg8::URA3 
kar1-1 

o
 [50] 
NB40-3C MATa lys2 leu2-3,112 ura3-52 his3∆HindIII 
arg8::hisG 

+
 cox2-62 [49] 
MR10 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::hisG 

+ 
atp6::ARG8
m
 [48] 
RKY105 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+ 
atp6-S175N This study 
RKY105-R1/3 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-I171F+S175N This study 
RKY105-R1/4 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-I239F+S175N This study 
RKY105-R2/3 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-I200M+S175N This study 
RKY105-R2/5 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-P12S+S175N This study 
RKY105-R6/5 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-S175K This study 
RKY105-R9/2 MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-S175I This study 
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RKY105-
R31/5 
MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-S175D This study 
RKY105-
R33/1 
MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-S175T This study 
RKY105-
R33/4 
MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-
1 CAN1 arg8::HIS3 

+
atp6-I171N+S175N This study 
 658 
 659 
  660 
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Table 2. Intragenic suppressors of the atp6-S175N mutation. 661 
 662 
Codon 
change 
Amino acid 
change 
Number 
Original mutant 
TCT175AAT S175N - 
Intragenic suppressors 
ATT171TTT I171F 8 
ATT171AAT I171N 1 
ATT239TTT I239F 35 
ATT200ATA I200M 1 
CCA12TCA P12S 3 
AAT175GAT N175D 2 
AAT175AAA N175K 1 
AAT175ATT N175I 2 
AAT175ACT N175T 1 
AAT175AGT N175S 6 
 663 
Table 3. Mitochondrial respiration ATP synthesis rates 664 
 665 
Strain 
Respiration rates 
nmol O.min
-1
.mg
-1
 
ATP synthesis rate 
nmol Pi.min
-1
.mg
-1
 
P/O 
% 
-
/
0
 
NADH 
NADH 
+ ADP 
NADH 
+ CCCP 
Asc/TMPD 
+ CCCP 
- oligo + oligo   
WT 410 ± 46 770 ± 40 1400 ± 195 2450 ± 283 828 ± 67 125 ± 21 1.08±0.03 <5% 
S175N 60 ± 5 60 ± 5 86 ± 5 1064 ± 620 82 ± 9 30 ± 10 1.37±0.04 <35% 
S175N+I200M 263 ± 58 572 ± 89 763 ± 152 2163 ± 144 729 ± 139 198 ± 64 1.27±0.16 <2% 
S175N+I171F 368 ± 81 781 ± 94 1422 ± 325 2886 ± 623 796 ± 26 429 ± 29 1.02±0.09 <3% 
S175N+I171N 122 ± 36 181 ± 74 332 ± 163 1549 ± 284 131 ± 7 74 ± 4 0.72±0.26 <4% 
S175N+P12S 254 ± 74 424 ± 97 910 ± 308 2603 ± 276 417 ± 34 146 ± 13 0.98±0.14 <6% 
S175N+I239F 195 ± 51 330 ± 57 660 ± 107 1854 ± 213 347 ± 77 146 ± 30 1.05±0.05 <7% 
S175D 385 ± 87 674 ± 123 1206 ± 263 2567 ± 186 410 ± 20 197 ± 22 0.61±0.08 <12% 
S175K 303 ± 49 488 ± 93 745 ± 232 1861 ± 137 360 ± 9 118 ± 11 0.74±0.12 <4% 
S175I 340 ± 33 738 ± 13 1104 ± 90 2863 ± 142 934 ± 51 184 ± 9 1.27±0.05 <4% 
S175T 249 ± 62 693 ± 186 772 ± 95 2278 ± 224 965 ± 16 397 ± 28 1.39±0.35 <6% 
 666 
Mitochondria were isolated from cells grown for 5-6 generations in rich galactose medium 667 
(YPGalA) at 28°C. Reaction mixes for assays contained 0.15 mg/mL protein, 4 mM NADH, 668 
150 (for respiration assays) or 750 (for ATP synthesis) µM ADP, 12.5 mM ascorbate (Asc), 669 
31 
 
1.4 mM N,N,N,N,-tetramethyl-p-phenylenediamine (TMPD), 4 µM carbonyl cyanide-m-670 
chlorophenyl hydrazone (CCCP), 3 µg/mL oligomycin (oligo). The values reported are 671 
averages of triplicate assays ± standard errors. The percentages of % -/o in cultures are 672 
indicated. 673 
 674 
 675 
 676 
 677 
